Relative quantitation of protein-protein interaction strength within the yeast two-hybrid system via fluorescence β-galactosidase activity detection in a high-throughput and low-cost manner

Assay and Drug Development Technologies

Volumn 4, Issue 6, 2006, Pages 709-719

  Oender, K ^a   Niedermayr, P ^a   Hintner, H ^a   Richter, K ^b   Koller, L ^b   Trost, A ^a   Bauer, J W ^a   Hundsberger, H ^c  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF SALZBURG   (Austria)

^c IMC UNIVERSITY OF APPLIED SCIENCES KREMS   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; TRANSFORMING GROWTH FACTOR BETA2;

ACCURACY; ARTICLE; CELL LYSATE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOLYSIS; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; GENE LIBRARY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; INCUBATION TIME; KERATINOCYTE; MOLECULAR CLONING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SENSITIVITY ANALYSIS; TWO HYBRID SYSTEM; YEAST CELL;

BETA-GALACTOSIDASE; COST-BENEFIT ANALYSIS; FALSE POSITIVE REACTIONS; FLUORESCENCE; GENE LIBRARY; HUMANS; KERATINOCYTES; ORGANIC CHEMICALS; PROTEIN INTERACTION MAPPING; SENSITIVITY AND SPECIFICITY; TWO-HYBRID SYSTEM TECHNIQUES; YEASTS;

EID: 33846874968     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2006.4.709     Document Type: Article

References (20)

1. Fields S, Song OK: A novel genetic system to detect protein-protein interactions. Nature 1989;340:245-246.
2. Fields S, Sternglanz R: The two-hybrid system: an assay for Protein-Protein Interactions. Trends Genet 1994;10:286-292.
3. Zanzoni A, Montecchi-Palazzi L, Quondam M, Ansiello G, Helmer-Citterich M, Cesarei G: Mint: a Molecular INTeraction database. FEBS Lett 2002;513:135-140.
4. Lappe M, Holm L: Unraveling protein interaction networks with near-optimal efficiency. Nat Biotechnol 2004;22: 98-103.
5. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, et al.: A comprehensive analysis of protein-protein Interactions in Saccharomyces cerevisiae. Nature 2000;403:623-627.
6. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y: A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA 2001;98:4569-4574.
7. Hazbun TR, Fields S: Networking proteins in yeast. Proc Natl Acad Sci USA 2001;98:4277-4278.
8. Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, Adams SL, et al.: Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 2002;415:180-183.
9. Gavin A-C, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, et al.: Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 2002;415:141-147.
10. von Mering C, Krause R, Snel B, Cornell M, Oliver SG, Fields S, et al.: Comparative assessment of large-scale data sets of protein-protein Interactions. Nature 2002;417: 399-403.
11. Grigoriev A: On the number of protein-protein Interactions in the yeast proteome. Nucleic Acids Res 2003;31:4157-4161.
12. Serebriiskii IG, Golemis EA: Two-hybrid system and false-positives. Approaches to detection and elimination. Methods Mol Biol 2001;177:123-134.
13. Serebriiskii I, Estojak J, Berman M, Golemis EA: Approaches to detecting false-positives in yeast two-hybrid systems. Biotechniques 2000;28:328-330, 332-336.
14. Kalnins A, Otto K, Ruther U, Muller-Hill B: Sequence of the lacZ gene of Escherichia coli. EMBO J 1983;2: 593-597.
15. Serebriiskii I, Toby G, Golemis E: Streamlined yeast colorimetric reporter activity assays, using scanners and plate readers. Biotechniques 2001;29:278-288.
16. Eustice DC, Feldman PA, Colberg-Poley AM, Buckery RM, Neubauer RH: A sensitive method for the detection of beta-galactosidase in transfected mammalian cells. Biotechniques 1991;11:739-740, 742-743.
17. Serebriiskii IG, Golemis EA: Uses of lacZ to study gene function: evaluation of beta-galactosidase assays employed in the yeast two-hybrid system. Anal Biochem 2000;285: 1-15.
18. Yingling JM, Blanchard KL, Sawyer JS: Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov 2004;3:1011-1022.
19. de Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlusener H, et al.: Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J 1987;6:3673-3677.
20. Madisen L, Webb NR, Rose TM, Marquardt H, Ikeda T, Twardzik D, et al.: Transforming growth factor-beta 2: cDNA cloning and sequence analysis. DNA 1988;7:1-8.